Brigham and Women's CEO steps down from board of Moderna

Moderna Inc., the drug developer conducting a high-profile clinical trial of a vaccine for the Covid-19 coronavirus, said Friday that Betsy Nabel, the president of Brigham and Women's Hospital, has stepped down from its board of directors to avoid what it called "the potential of even apparent conflict of interest." Moderna (Nasdaq: MRNA) said that Nabel had resigned effective Thursday, July 30 after five years serving as a board member. In a release about her resignation, which came after the Boston…